Journal of Neurosurgery: Spine published the study.
Here are five takeaways:
1. Researchers developed an overexpression of the gene SMURF2, which is involved in tumor formation as well as disease progression.
2. The study dove into the molecular mechanisms complicit in the breakdown of the spine’s soft tissue discs.
3. With the knowledge of molecular pathways that lead to disc degradation, researchers will be able to create therapies to block these mechanisms or encourage repair.
4. This study propels more than three years of SMURF2 research forward.
5. Researchers are currently working on the next phase of the study, which will focus on human tissue.
More articles on spine:
Treating back pain requires informed patients, judicious doctors
8 things for spine surgeons to know for Thursday — April 27, 2017
5 trends in spinal fusion BMP use — Did the FDA advisory or journal warning have a bigger impact?
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.